Sponsor study identifier
interventional
32
1 country
1
Study Start
October 16, 2024
Actual (reported)Primary Completion
December 28, 2024
Actual (reported)Study Completion
December 28, 2024
Actual (reported)This study evaluated the effects of eight weeks of high-intensity interval training (HIIT), daily quinoa consumption, and their combination on inflammatory markers and blood glucose control in women aged 50-65 years with type 2 diabetes. Participants were randomly assigned to four groups: HIIT, quinoa consumption, combined HIIT and quinoa consumption, or control. The quinoa groups consumed 25 g of cooked quinoa daily for eight weeks. Blood markers and body measurements were assessed before and after the intervention.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 28, 2024
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
October 16, 2024
Actual (reported)December 28, 2024
Actual (reported)December 28, 2024
Actual (reported)October 2, 2026
Actual (reported)October 7, 2026
Actual (reported)NLRP3
A circulating marker of inflammasome activation/pyroptosis, measured in fasting serum using an ELISA assay.
Baseline
NLRP3
A circulating marker of inflammasome activation/pyroptosis, measured in fasting serum using an ELISA assay.
8-weeks
IL-18
Baseline
IL-18
8-weeks
HbA1c
Baseline
HbA1c
8-weeks
Fasting blood glucose
Baseline
Supervised HIIT three times per week for 8 weeks (24 sessions). Each repetition consisted of a 40 m shuttle run (10 m + 20 m + 10 m), followed by 30 seconds of active recovery. Training progressed from 4 repetitions in weeks 1-2, 5 in weeks 3-4, 6 in weeks 5-6, and 8 in weeks 7-8, performed at 85-90% of age-predicted maximum heart rate.
25 g/day of cooked quinoa seeds as a morning snack between 10:00 and 11:00 AM, every day for 8 weeks.
Allameh Tabataba'i University
Tehran, 14896-84511, Iran
32 participants (actual enrollment reported by the registry).
First Submitted
October 2, 2026
First Posted
October 7, 2026
Study Start
October 16, 2024
Actual (reported)FreeStyle Libre Monitoring in T2DM
Participants completed the same 8-week HIIT programme and simultaneously consumed 25 g/day of cooked quinoa using the same supplementation schedule.
Participants received no HIIT and no quinoa supplementation. They were instructed to maintain their usual diet, medication use and habitual physical activity, and not to begin any new exercise, dietary or supplementation programme during the 8-week trial.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Primary Completion
December 28, 2024
Actual (reported)Study Completion
December 28, 2024
Actual (reported)Last Updated
October 7, 2026
Record last verified: 2026-10
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: